Interval Safety Layer Coupled With an Impulsive MPC for Artificial Pancreas to Handle Intrapatient Variability
Интервальный слой безопасности в сочетании с импульсным MPC для искусственной поджелудочной железы с целью учета внутрипациентной вариабельности
2022-02-21
SCID: 54.1/k7yccscj
Discuss with AI
adaptive insulin-on-board constraintartificial pancreasimpulsive model predictive controlinterval modelintrapatient variability
Figures from the paper
Abstract (AI)
The aim of control strategies for artificial pancreas systems is to calculate the insulin doses required by a subject with type 1 diabetes to regulate blood glucose levels by reducing hyperglycemia and avoiding the induction of hypoglycemia. Several control formulations developed for this end involve a safety constraint given by the insulin on board (IOB) estimation. This constraint has the purpose of reducing hypoglycemic episodes caused by insulin stacking. However, intrapatient variability constantly changes the patient's response to insulin, and thus, an adaptive method is required to restrict the control action according to the current situation of the subject. In this work, the control action computed by an impulsive model predictive controller is modulated with a safety layer to satisfy an adaptive IOB constraint. This constraint is established with two main steps. First, upper and lower IOB bounds are generated with an interval model that accounts for parameter uncertainty, and thus, define the possible system responses. Second, the constraint is selected according to the current value of glycemia, an estimation of the plant-model mismatch, and their corresponding first and second time derivatives to anticipate the changes of both glucose levels and physiological variations. With this strategy satisfactory results were obtained in an adult cohort where random circadian variability and sensor noise were considered. A 92% time in normoglycemia was obtained, representing an increase of time in range compared to previous MPC strategies, and a reduction of time in hypoglycemia to 0% was achieved without dangerously increasing the time in hyperglycemia.
Key Findings
1
An adaptive safety layer modulates impulsive model predictive control to regulate insulin delivery under intrapatient variability.
2
An interval model generates upper and lower insulin-on-board bounds that account for parameter uncertainty and possible system responses.
3
In an adult cohort with random circadian variability and sensor noise, the strategy achieved 92% time in normoglycemia.
4
The approach reduced time in hypoglycemia to 0% without dangerously increasing hyperglycemia, improving time in range over previous MPC strategies.
5
The selected IOB constraint uses glycemia, estimated plant-model mismatch, and their first and second derivatives to anticipate glucose and physiological changes.
Research Object
Artificial pancreas control system for adults with type 1 diabetes under intrapatient variability
Research Subject
Adaptive insulin dosing safety and glycemic-control performance using an interval IOB constraint coupled with impulsive MPC
Publication Details
Publication Date
2022-02-21
Journal
Frontiers in Endocrinology
Publisher
Frontiers Media
ISSN
1664-2392
Cited by
8
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
Safety Constraints in an Artificial Pancreatic β Cell: An Implementation of Model Predictive Control with Insulin on Board2009
Individualized model predictive control for the artificial pancreas: In silico evaluation of closed-loop glucose control2018
Adaptive Zone Model Predictive Control of Artificial Pancreas Based on Glucose- and Velocity-Dependent Control Penalties2018
The Artificial Pancreas and Meal Control: An Overview of Postprandial Glucose Regulation in Type 1 Diabetes2018